CN105560192A — 一种棕榈酸帕利哌酮长效微球注射液的制备方法
Assigned to WANQUAN WANTE PHARMACEUTICAL JIANGSU Co Ltd · Expires 2016-05-11 · 10y expired
What this patent protects
本发明公开了一种棕榈酸帕利哌酮长效微球注射液的制备方法,其制备工艺主要包含以下几个步骤:(1)将棕榈酸帕利哌酮与高分子聚合物共溶于有机溶剂中制成溶液;(2)将步骤(1)所得溶液置于喷雾干燥机的载物台上,开启搅拌设备,打开空气压缩机,调整仪器参数,用喷雾干燥法制备载药微球;(3)将步骤(2)所得微球重分散于含有表面活性剂、助悬剂、缓冲盐、pH调节剂和水的稀释液中制备成长效微球注射液。本发明步骤简洁、易于操作、条件温和、适合大规模生产,所得微球外形光滑圆整、包封率高。本发明的长效微球注射液释药平稳持久,缓释效果好。
USPTO Abstract
本发明公开了一种棕榈酸帕利哌酮长效微球注射液的制备方法,其制备工艺主要包含以下几个步骤:(1)将棕榈酸帕利哌酮与高分子聚合物共溶于有机溶剂中制成溶液;(2)将步骤(1)所得溶液置于喷雾干燥机的载物台上,开启搅拌设备,打开空气压缩机,调整仪器参数,用喷雾干燥法制备载药微球;(3)将步骤(2)所得微球重分散于含有表面活性剂、助悬剂、缓冲盐、pH调节剂和水的稀释液中制备成长效微球注射液。本发明步骤简洁、易于操作、条件温和、适合大规模生产,所得微球外形光滑圆整、包封率高。本发明的长效微球注射液释药平稳持久,缓释效果好。
Drugs covered by this patent
- Risperdal (risperidone) · Johnson & Johnson (Janssen)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.